Prosecution Insights
Prosecution Insights
6 pending office actions • 5 clients • 5 examiners • 4 art units • 0 of 6 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (83%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLIENTZ, LEAH H | 2 | 42.2% | +38.8% |
| SEVERSON, RYAN J | 1 | 83.0% | +13.4% |
| DALE, ABIGAYLE ANN | 1 | 30.8% | +81.8% |
| MEJIAS, SAMANTHA LEE | 1 | 47.4% | +62.5% |
| MOORE, SUSANNA | 1 | 68.1% | +31.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18268555 | Side Port For Addition Of Multiple Drugs To A Nebulizer | DALE, ABIGAYLE ANN | 44d overdue |
| 17792369 | PURIFICATION METHOD OF PROGESTERONE | MOORE, SUSANNA | 24d overdue |
| 19070153 | NATURAL FIBERS HAVING ABSORBABLE AND HYDROPHOBIC PROPERTIES FOR MAKING SURGICAL SUTURES AND SURGICAL MESHES | SEVERSON, RYAN J | 4d overdue |
| 17998712 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | SCHLIENTZ, LEAH H | 26d |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | SCHLIENTZ, LEAH H | 39d |
| 18000679 | PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING | MEJIAS, SAMANTHA LEE | 57d |
| Client (Assignee) | Pending OAs |
|---|---|
| UNIVERSITY OF COPENHAGEN | 2 |
| Ballast Medical | 1 |
| InspiRx, Inc. | 1 |
| Albert-Ludwigs-Universität Freiburg | 1 |
| Zhejiang Shenzhou | 1 |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| 3771 | 1 |
| 3785 | 1 |
| 1624 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19070153 | NATURAL FIBERS HAVING ABSORBABLE AND HYDROPHOBIC PROPERTIES FOR MAKING SURGICAL SUTURES AND SURGICAL MESHES | BALLAST MEDICAL INC. | SEVERSON, RYAN J | 3771 | Other | Non-Final OA | 4d overdue | Pending | Mar 04, 2025 |
| 18268555 | Side Port For Addition Of Multiple Drugs To A Nebulizer | Inspirx, Inc. | DALE, ABIGAYLE ANN | 3785 | §103 | Non-Final OA | 44d overdue | Pending | Jun 20, 2023 |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | UNIVERSITY OF COPENHAGEN | SCHLIENTZ, LEAH H | 1618 | §103 | Non-Final OA | 39d | Pending | Feb 16, 2023 |
| 18000679 | PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING | Albert-Ludwigs-Universität Freiburg | MEJIAS, SAMANTHA LEE | 1618 | §103 | Final Rejection | 57d | Pending | Dec 04, 2022 |
| 17998712 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | UNIVERSITY OF COPENHAGEN | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | 26d | Pending | Nov 14, 2022 |
| 17792369 | PURIFICATION METHOD OF PROGESTERONE | Zhejiang Shenzhou Pharmaceutical Company Limited | MOORE, SUSANNA | 1624 | §103 | Final Rejection | 24d overdue | Pending | Jul 12, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial